La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Micro-Tech (Nanjing)Ltd Résultats passés
Passé contrôle des critères 5/6
Micro-Tech (Nanjing)Ltd has been growing earnings at an average annual rate of 15.6%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 17% per year. Micro-Tech (Nanjing)Ltd's return on equity is 14.2%, and it has net margins of 21.3%.
Informations clés
15.6%
Taux de croissance des bénéfices
11.2%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 16.0% |
| Taux de croissance des recettes | 17.0% |
| Rendement des fonds propres | 14.2% |
| Marge nette | 21.3% |
| Prochaine mise à jour des résultats | 23 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Here's What's Concerning About Micro-Tech (Nanjing)Ltd's (SHSE:688029) Returns On Capital
Aug 07
Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Earnings Are Not Doing Enough For Some Investors
Jul 16An Intrinsic Calculation For Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) Suggests It's 22% Undervalued
Apr 17Micro-Tech (Nanjing)Ltd (SHSE:688029) Is Reinvesting At Lower Rates Of Return
Mar 19Ventilation des recettes et des dépenses
Comment Micro-Tech (Nanjing)Ltd gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 24 | 2,481 | 528 | 933 | 146 |
| 31 Dec 23 | 2,411 | 486 | 904 | 151 |
| 30 Sep 23 | 2,213 | 490 | 783 | 146 |
| 30 Jun 23 | 2,167 | 470 | 786 | 150 |
| 31 Mar 23 | 2,088 | 389 | 757 | 160 |
| 31 Dec 22 | 1,980 | 331 | 743 | 165 |
| 30 Sep 22 | 2,070 | 303 | 792 | 174 |
| 30 Jun 22 | 2,032 | 306 | 768 | 178 |
| 31 Mar 22 | 1,996 | 301 | 756 | 166 |
| 31 Dec 21 | 1,947 | 325 | 736 | 153 |
| 30 Sep 21 | 1,784 | 301 | 668 | 136 |
| 30 Jun 21 | 1,631 | 290 | 620 | 121 |
| 31 Mar 21 | 1,473 | 280 | 552 | 109 |
| 31 Dec 20 | 1,326 | 261 | 501 | 100 |
| 30 Sep 20 | 1,278 | 285 | 488 | 90 |
| 30 Jun 20 | 1,260 | 267 | 476 | 78 |
| 31 Mar 20 | 1,267 | 287 | 473 | 75 |
| 31 Dec 19 | 1,307 | 304 | 455 | 70 |
| 30 Sep 19 | 1,202 | 256 | 415 | 62 |
| 30 Jun 19 | 1,099 | 228 | 380 | 60 |
| 31 Mar 19 | 989 | 199 | 337 | 53 |
| 31 Dec 18 | 922 | 193 | 314 | 49 |
| 30 Jun 18 | 763 | 150 | 233 | 58 |
| 31 Mar 18 | 702 | 126 | 219 | 48 |
| 31 Dec 17 | 641 | 101 | 205 | 38 |
| 31 Dec 16 | 414 | -36 | 230 | 18 |
| 31 Dec 15 | 261 | 31 | 85 | 0 |
| 31 Dec 14 | 203 | 29 | 63 | 0 |
| 31 Dec 13 | 169 | 25 | 53 | 0 |
Des revenus de qualité: 688029 has high quality earnings.
Augmentation de la marge bénéficiaire: 688029's current net profit margins (21.3%) are higher than last year (18.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688029's earnings have grown by 15.6% per year over the past 5 years.
Accélération de la croissance: 688029's earnings growth over the past year (35.8%) exceeds its 5-year average (15.6% per year).
Bénéfices par rapport au secteur d'activité: 688029 earnings growth over the past year (35.8%) exceeded the Medical Equipment industry 1.7%.
Rendement des fonds propres
ROE élevé: 688029's Return on Equity (14.2%) is considered low.